162 related articles for article (PubMed ID: 22935939)
21. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
Hamblin S; Rumbaugh K; Miller R
J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
[TBL] [Abstract][Full Text] [Related]
22. Implementation of performance metrics to assess pharmacists' activities in ambulatory care clinics.
Schmidt L; Klink C; Iglar A; Sharpe N
Am J Health Syst Pharm; 2017 Jan; 74(1):e76-e82. PubMed ID: 28007725
[TBL] [Abstract][Full Text] [Related]
23. Clinical effectiveness and cost savings in diabetes care, supported by pharmacist counselling.
Rodriguez de Bittner M; Chirikov VV; Breunig IM; Zaghab RW; Shaya FT
J Am Pharm Assoc (2003); 2017; 57(1):102-108.e4. PubMed ID: 27769877
[TBL] [Abstract][Full Text] [Related]
24. International Normalized Ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic.
Griffin BL; Burkiewicz JS; Peppers LR; Warholak TL
Am J Health Syst Pharm; 2009 Jul; 66(13):1218-23. PubMed ID: 19535661
[TBL] [Abstract][Full Text] [Related]
25. Potential impact of pharmacist interventions to reduce cost for Medicare Part D beneficiaries.
Thatcher EE; Vanwert EM; Erickson SR
J Pharm Pract; 2013 Jun; 26(3):248-52. PubMed ID: 23178417
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
[TBL] [Abstract][Full Text] [Related]
27. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model.
Nesbit TW; Shermock KM; Bobek MB; Capozzi DL; Flores PA; Leonard MC; Long JK; Militello MA; White DA; Barone LD; Goldman MP; Kvancz DA
Am J Health Syst Pharm; 2001 May; 58(9):784-90. PubMed ID: 11351918
[TBL] [Abstract][Full Text] [Related]
28. Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC).
Kislan MM; Bernstein AT; Fearrington LR; Ives TJ
BMC Health Serv Res; 2016 Oct; 16(1):607. PubMed ID: 27769219
[TBL] [Abstract][Full Text] [Related]
29. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
Skelton JB; ;
J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
[TBL] [Abstract][Full Text] [Related]
30. Economic effects of pharmacists on health outcomes in the United States: A systematic review.
Chisholm-Burns MA; Graff Zivin JS; Lee JK; Spivey CA; Slack M; Herrier RN; Hall-Lipsy E; Abraham I; Palmer J
Am J Health Syst Pharm; 2010 Oct; 67(19):1624-34. PubMed ID: 20852164
[TBL] [Abstract][Full Text] [Related]
31. Spirometry: tool for pharmacy practitioners to expand direct patient care services.
Cawley MJ; Moon J; Reinhold J; Willey VJ; Warning Ii WJ
J Am Pharm Assoc (2003); 2013; 53(3):307-15. PubMed ID: 23699680
[TBL] [Abstract][Full Text] [Related]
32. Pharmacist-managed medication review in a managed care system.
Borgsdorf LR; Miano JS; Knapp KK
Am J Hosp Pharm; 1994 Mar; 51(6):772-7. PubMed ID: 8010315
[TBL] [Abstract][Full Text] [Related]
33. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.
DeName B; Divine H; Nicholas A; Steinke DT; Johnson CL
J Am Pharm Assoc (2003); 2008; 48(6):731-6. PubMed ID: 19019801
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis of doctor-pharmacist collaborative prescribing for venous thromboembolism in high risk surgical patients.
Hale A; Merlo G; Nissen L; Coombes I; Graves N
BMC Health Serv Res; 2018 Oct; 18(1):749. PubMed ID: 30285744
[TBL] [Abstract][Full Text] [Related]
35. Comparison of two different models of anticoagulation management services with usual medical care.
Rudd KM; Dier JG
Pharmacotherapy; 2010 Apr; 30(4):330-8. PubMed ID: 20334453
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of a pharmacist-managed medication refill program.
Billups SJ; Delate T; Newlon C; Schwiesow S; Jahnke R; Nadrash A
J Am Pharm Assoc (2003); 2013; 53(5):505-12. PubMed ID: 24030128
[TBL] [Abstract][Full Text] [Related]
37. A cost-consequences analysis of an adherence focused pharmacist-led medication review service.
Desborough JA; Sach T; Bhattacharya D; Holland RC; Wright DJ
Int J Pharm Pract; 2012 Feb; 20(1):41-9. PubMed ID: 22236179
[TBL] [Abstract][Full Text] [Related]
38. Economic evaluations of clinical pharmacy services: 2006-2010.
Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
[TBL] [Abstract][Full Text] [Related]
39. Drug therapy problems and medication discrepancies during care transitions in super-utilizers.
Surbhi S; Munshi KD; Bell PC; Bailey JE
J Am Pharm Assoc (2003); 2016; 56(6):633-642.e1. PubMed ID: 27720595
[TBL] [Abstract][Full Text] [Related]
40. Implementation of a drug therapy monitoring clinic in a primary-care setting.
Yanchick JK
Am J Health Syst Pharm; 2000 Dec; 57 Suppl 4():S30-4. PubMed ID: 11148942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
